BRUCATO, Federica
 Distribuzione geografica
Continente #
NA - Nord America 357
EU - Europa 80
AS - Asia 24
OC - Oceania 1
Totale 462
Nazione #
US - Stati Uniti d'America 357
IT - Italia 42
SG - Singapore 14
DE - Germania 13
IE - Irlanda 8
CN - Cina 7
GB - Regno Unito 7
FI - Finlandia 3
BE - Belgio 2
AT - Austria 1
AU - Australia 1
IN - India 1
JP - Giappone 1
KR - Corea 1
LV - Lettonia 1
MK - Macedonia 1
SE - Svezia 1
UA - Ucraina 1
Totale 462
Città #
Chandler 94
Ashburn 44
Fairfield 19
New York 18
Medford 16
Seattle 13
Altamura 12
Woodbridge 12
Ann Arbor 11
Cambridge 10
Princeton 10
Venice 10
Lawrence 9
Wilmington 9
San Diego 8
Bremen 7
Houston 7
Singapore 7
Dublin 6
Des Moines 5
Cagliari 4
London 4
Beijing 2
Boardman 2
Brussels 2
Halver 2
Helsinki 2
Menlo Park 2
Munich 2
Palermo 2
Partinico 2
Fuzhou 1
Haikou 1
Hounslow 1
Innsbruck 1
Kilburn 1
Lappeenranta 1
Ludwigshafen am Rhein 1
Miami 1
Nanjing 1
Pune 1
Riga 1
Seongnam 1
Southwark 1
Tokyo 1
Washington 1
Zhengzhou 1
Totale 369
Nome #
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 145
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 58
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients 53
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY 43
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC 42
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects: Polygenic hypocholesterolemias 42
GENETIC MARKERS OF DEVELOPMENT AND PROGRESSION OF THE ATHEROSCLEROSIS. POSSIBLE ROLE OF VARIANTS THAT CHANGE THE INTERACTIONS WITH THE PROTEOGLYCANS AND LIFETIME EXPOSURE TO LIPID RISK FACTORS IN CARDIOVASCULAR HIGH-RISK PATIENTS 41
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS 38
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY 35
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES" 31
Totale 528
Categoria #
all - tutte 3.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 7 6 3 6 3 5 2
2020/202155 1 7 9 0 7 0 13 1 5 0 12 0
2021/2022126 3 7 12 3 2 1 2 4 4 44 10 34
2022/2023212 16 43 0 28 17 30 4 25 37 0 8 4
2023/202496 1 11 3 23 4 25 8 7 0 0 2 12
2024/20257 1 6 0 0 0 0 0 0 0 0 0 0
Totale 528